Диссертация (1154806), страница 21
Текст из файла (страница 21)
Сидоренко, В. В. Рафальский, Т. В. Спичак. - ИздательствоПресто, 2014. - 19 - 20 с.60.Сычев, Д. А. Полипрагмазия в клинической практике: проблема и решения /Д. А. Сычев, В. А. Отделенов. - СПб.: ЦОП «Профессия», 2016. - 224 с.61.Тиктинский, О.Л. Пиелонефриты / О.
Л. Тиктинский, С. Н. Калинина. СПб.: СПбМАПО, Медиа Пресс, 1996. - 200 с.62.Федеральный закон РФ от от 12.04.2010 № 61-ФЗ "Об обращениилекарственных средств".12863.Фоминых, С. Г. Рейтинг врачебных заблуждений при назначенииантимикробных средств: ретроспективный анализ экспертной работы врачаклинического фармаколога / С. Г.
Фоминых // Клиническая микробиологияи антимикробная химиотерапия. - 2017. - Т. 19. - №1. - С. 73 - 79.64.Хосева, Е.Н. Проблемные аспекты развития системы фармаконадзора вРоссийской Федерации на современном этапе (обзор) / Е.Н. Хосева, Т.Е.Морозова // Качественная клиническая практика. – 2013. - №3. – С. 40-45.65.Якимова, Ю. Н. Поведение фармацевтических работников при отпускеантибиотиков для системного применения / Ю. Н. Якимова, О. В.
Решетько// Фармакоэкономика: теория и практика. - 2016. - №1. - С. 225.66.Яковлев,С.В.Нозокомиальныеинфекции,вызванныеполирезистентными грамотрицательными микроорганизмами: как с нимибороться? / С. В. Яковлев // Consilium Medicum. - 2008. - Т. 10. - №1.
- С. 44- 49.67.A prospective study on Adverse Drug Reactions of antibiotics in a tertiary carehospital / M. Shamna, C. Dilip, M. Ajmal et al. // Saudi Pharm J. - 2014. - Vol.22. - №4. - P. 303 - 308.68.Adverse Drug Events Occurring Following Hospital Discharge / A. J. Forster, H.J. Muff, J. F. Peterson, D.
W. Bates // Journal of General Internal Medicine. 2005. - №20. - P. 317 - 323.69.Adverse Drug Reactions in Children - A Systematic Review / R. M. D. Smyth, E.Gargon, J. Kirkham et al. // PLoS ONE. - 2012. - Vol. 7. - №3. - e2406170.An in depth investigation into causes of prescribing errors by foundation traineesin relation to their medical education. EQIP Study / T.
Dornan, D. Ashcroft, H.Heathfield et al. - London: General Medical Council, 2009. - 1 - 215 p.71.Antibiotic resistance threats in the United States, 2013 // U. S. Department ofHealth and Human Services. Centers for disease Control and Prevention, 2013. 6 p.12972.Aronson, J. K. Medication errors: definitions and classification / J. K. Aronson//Br. J Clin Phamacol. - 2009.
- Vol. 67. - №6. - P. 599 - 604.73.Aronson, J. K. Side Effects of Drugs Annual 33. A worldwide yearly survey ofnew data in adverse drug reactions. / J. K. Aronson. - Elsevier, 2011. - 492 p.74.Aronson, J.K. Medication errors: what they are, how they happen, and how toavoid them / J. K. Aronson // Quarterly Journal of Medicine.
- 2009. - №102. - P.513-521.75.Assessing the usability of methods of public reporting of adverse drug reactionsto the UK Yellow Card Scheme / C. Anderson, A. Gifford, A. Avery et al. //Health Expectations. - 2012. - Vol. 15. - №4. - P. 433 – 440.76.Benjamin, D. Reducing medication errors and increasing patient safety: casestudies in clinical pharmacology / D. Benjamin // Journal of ClinicalPharmacology. - 2003. - Vol.
43. - №7. - P. 768 – 783.77.Bergvall, T. vigiGrade: A tool to identify well-documented individual casereports and highlight systematic data quality issues / T. Bergvall, G. N. Norén, M.Lindquist // Drug Safety. - 2014. - Vol. 37. - №1. - P. 65 - 77.78.Berman, A. Reducing medication errors through naming, labeling, and packaging/ A. Berman // J Med Syst. - 2004. - №28. - P.
9 – 29.79.Brosch, S. Good practice: MedDRA coding of case reports resulting in harm.European Union Regulatory Workshop on Medication Errors. [Электронныйресурс] / S. Brosch // European Medicines Agency. - 2013. Режим доступа:http://www.ema.europa.eu/docs/en_GB/document_library/Presentation/2013/03/WC500139872.pdf80.Can causality assessment fulfill the new European definition of adverse drugreaction? A review of methods used in spontaneous reporting / A.
Mascolo, C.Scavone, M. Sessa et al. // Pharmacol Res. - 2017. -№123. - P. 122 - 129.81.Carney, S. L. Medication accuracy and general practitioner referral letters / S. L.Carney // Intern Med J. - 2006. - №36. - P. 132 - 134.13082.Castro-Pastrana, L.
I. Improving pediatric drug safety: need for more efficientclinical translation of pharmacovigilance knowledge / L. I. Castro-Pastrana, B. C.Carleton // J Popul Ther Clin Pharmacol.- 2011. - №18. - e76-88.83.Characteristics and quality of adverse drug reaction reports by pharmacists inNorway/A.Gedde-Dahl,P.Harg,H.Stenberg-Nilsenetal.//Pharmacoepidemiol Drug Saf. - 2007. - Vol. 16.
- №9. - P. 999 - 1005.84.Dimant, J. Medication Errors and Adverse Drug Events in Nursing Homes:Problems, Causes, Regulations, and Proposed Solutions / J. Dimant // Journal ofthe American Medical Directors Association. - 2001.
- №2. - P. 81 - 93.85.Drug-induced gingival hyperplasia: a retrospective study using spontaneousreporting system databases / H. Hatahira, J. Abe, Y. Hane et al. // J Pharm HealthCare Sci. - 2017. - №3. - P. 19.86.Drug-related deaths: an analysis of the Italian spontaneous reporting database / R.Leone, L. Sottosanti, M. L. Iorio et al. // Drug Saf.
- 2008. - Vol. 31. - №8. - P.703 - 713.87.DSM Group. Рейтинг продаж антибиотиков в России 2016 [Электронныйресурс]//DSMGroup.–2016.–Режимдоступа:http://www.dsm.ru/news/269/?sphrase_id=566588.DSM Group. Фармацевтический рынок России 2013 [Электронный ресурс] //DSMGroup.–2013.–Режимдоступа:http://www.dsm.ru/docs/analytics/dsm_report2013.pdf89.Duguid, M. The importance of medication reconciliation for patients andpractitioners / M. Duguid // Australian Prescriber. - 2012. - №35. - P.
15 – 19.90.Edwards, I. R. Adverse drug reactions: definitions, diagnosis, and management /I. R. Edwards, J. K. Aronson // Lancet. - 2000. - №356 (9237). - Р. 1255-1259.91.Emergency Department Visits for Antibiotic-Associated Adverse Events / N.Shehab, P. R. Patel, A. Srinivasan, D. S.
Budnitz // Clin Infect Dis. - 2008. №47. - P. 735 - 743.13192.EULAR recommendations for the treatment of systemic sclerosis: a report fromthe EULAR Scleroderma Trials and Research group (EUSTAR) / O. KowalBielecka, R. Landewé, J. Avouac et al. // Ann Rheum Dis. - 2009. - №68. - P. 620- 628.93.Evaluation of Perioperative Medication Errors and Adverse Drug Events / K. C.Nanji, A. Patel, S. Shaikh et al. // Anesthesiology. - 2016. - №124. - P. 25 - 34.94.Experiences with adverse drug reaction reporting by patients: an 11-countrysurvey / F. Van Hunsel, L. Harmark, S. Pal S et al. // Drag Saf.
- 2012. - Vol. 35.- №1 - P. 45 - 60.95.Exploratory toxicology as an integrated part of drug discovery. Part I: Why andhow / J. J.Hornberg, M. Laursen, N. Brenden et al. // Drug Discov Today. - 2014.- Vol. 19. - №8. - P. 1131 - 1136.96.Fatal case of cephalexin-induced toxic epidermal necrolysis [Электронныйресурс] / M. J. Hafermann, G. R. Barber, S. C. Dreskin, G. K. Lindberg // SAGEOpenMedicalCaseReports.-2014.Режим-доступа:http://journals.sagepub.com/doi/10.1177/2050313X1453225097.FDA Consumer Health Information [Электронный ресурс] // U.S.
Food andDrugAdministration.-2009.-Режимдоступа:http://www.fda.gov/downloads/ForConsumers/ConsumerUpdates/UCM143038.pdf98.Fontanarosa, P.B. Postmarketing surveillance - lack of vigilance, lack of trust / P.B. Fontanarosa, D. Rennie, C. D. DeAngelis // JAMA. - 2004. - №292. - P. 2647- 2650.99.Gandhi, T. K. Identifying drug safety issues: from research to practice / T. K.Gandhi, D. L. Seger, D.
W. Bates // International Journal for Quality in HealthCare. - 2000. - Vol. 12. - №1. - P. 69 - 76.100. Goldman, S. A. Communication of medical product risk: how effective iseffective enough? / S. A. Goldman // Drug Saf. - 2004. - №27. - P.
519 - 534.132101. Good practice guide on recording, coding, reporting and assessment ofmedication errors [Электронный ресурс] // European Medicines Agency. - 2015.-Режимдоступа:http://www.ema.europa.eu/docs/en_GB/document_library/Regulatory_and_procedural_guideline/2015/04/WC500185536.pdf102. Grigoryan, L. Attitudes, beliefs and knowledge concerning antibiotic use andself-medication: a comparative European study / L. Grigoryan, J.G. Burgerhof,J.E. Degener [et al.] // Pharmacoepidemiol Drug Saf. – 2007.
– Vol. 16. – № 11.– P. 1234-1243.103. Guideline on good pharmacovigilance practices (GVP) Module VI –Management and reporting of adverse reactions to medicinal products. - 2012. - 1- 90 p.104. Handler, S .M. Medication error reporting in long-term care / S. M. Handler,D. A. Nace, S. A. Studenski et al. // Am J Geriatr Pharmacother. - 2004. - №2. P. 190 – 196.105. Holquist, C. Medication errors: an FDA perspective. European UnionRegulatory Workshop on Medication Errors [Электронный ресурс] / С. Holquist// U.
S. Food and Drug Administration. - 2013. - Режим доступа:http://www.ema.europa.eu/docs/en_GB/document_library/Presentation/2013/03/WC500139886.pdf106. Incidence and Nature of Dosing Errors in Paediatric Medications / I. C. Wong,M. A. Ghaleb,B. D.Franklin, N. Barber // Drug-Safety. - 2004. - №27. - P. 661.107. Incidence and preventability of adverse drug events among older persons inthe ambulatory setting / J. H. Gurwitz, T. S. Field, L. R.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
